| Product Code: ETC8888066 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Lumasiran Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Lumasiran Market - Industry Life Cycle |
3.4 Portugal Lumasiran Market - Porter's Five Forces |
3.5 Portugal Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Portugal Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Portugal Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Portugal Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Portugal Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Portugal Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Portugal Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare diseases such as primary hyperoxaluria type 1 (PH1) in Portugal |
4.2.2 Growing investments in healthcare infrastructure and research and development in the country |
4.2.3 Rising awareness and adoption of innovative therapies for rare genetic disorders |
4.2.4 Favorable regulatory environment supporting the development and approval of orphan drugs |
4.3 Market Restraints |
4.3.1 High costs associated with lumasiran treatment limiting accessibility for patients |
4.3.2 Limited healthcare budget allocation for orphan drugs in Portugal |
4.3.3 Challenges in diagnosing rare diseases and identifying eligible patients for lumasiran therapy |
4.3.4 Competition from alternative treatment options for PH1 and related disorders |
5 Portugal Lumasiran Market Trends |
6 Portugal Lumasiran Market, By Types |
6.1 Portugal Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Portugal Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Portugal Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Portugal Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Portugal Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Portugal Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Portugal Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Portugal Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Portugal Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Portugal Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Portugal Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Portugal Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Portugal Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Portugal Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Portugal Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Portugal Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Portugal Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Portugal Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Portugal Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Portugal Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Portugal Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Portugal Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Portugal Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Portugal Lumasiran Market Import-Export Trade Statistics |
7.1 Portugal Lumasiran Market Export to Major Countries |
7.2 Portugal Lumasiran Market Imports from Major Countries |
8 Portugal Lumasiran Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for lumasiran in Portugal |
8.2 Number of healthcare facilities offering lumasiran therapy |
8.3 Adoption rate of lumasiran among eligible patients |
8.4 Patient satisfaction and adherence to lumasiran treatment |
8.5 Improvement in key biomarkers and clinical outcomes in patients receiving lumasiran |
9 Portugal Lumasiran Market - Opportunity Assessment |
9.1 Portugal Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Portugal Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Portugal Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Portugal Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Portugal Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Portugal Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Portugal Lumasiran Market - Competitive Landscape |
10.1 Portugal Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Portugal Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here